Literature DB >> 6159403

Phenotypic expression of I-A and I-E/C subregion determinants on murine thymocytes.

S O Sharrow, K Ozato, D H Sachs.   

Abstract

The expression of Ia antigens on murine thymocytes has been assessed by indirect immunofluorescence and flow microfluorometry analysis. Antisera specific for I-region determinants were found to react with at least 50% of thymus cells in single-cell suspensions. When these antisera were tested on thymus cells of an appropriate recombinant strain, it was found that both I-A and I-E/C subregion determinants could be detected. Monoclonal antibodies to I-A and to I-E determinants also reacted with thymus cells in a similar fashion, eliminating the possibility that contaminating specificities accounted for the reactivity of alloantisera. The majority of Ia-positive thymus cells appeared to express determinants encoded by genes of both I-A and I-E/C subregions. Ia expression on individual thymocytes was also correlated with cell size as measured by forward light scatter intensity. However, unlike antigens detected by rabbit anti-mouse brain antisera, Ia antigens did not appear to be associated with known subpopulations of thymocytes distinguishable by light scatter intensity. The presence of I-region encoded antigens on thymocytes may play a role in maturation of T cells in the thymus microenvironment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159403

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Anti-idiotype to monoclonal anti-swine SLA antibody detects a common idiotype shared by mouse anti-SLA sera and elicits an anti-SLA activity.

Authors:  R Rabinowitz; M D Pescovitz; D H Sachs
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

2.  Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.

Authors:  C C Zielinski; S K Datta; S D Waksal
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

3.  Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld.

Authors:  G A Evans; D H Margulies; R D Camerini-Otero; K Ozato; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Anti-idiotypes against anti-H-2 monoclonal antibodies: structural analysis of the molecules induced by in vivo anti-idiotype treatment.

Authors:  J A Bluestone; H C Krutzsch; H Auchincloss; P A Cazenave; T J Kindt; D H Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model.

Authors:  C J Gauntt; H M Arizpe; J T Kung; K K Ogilvie; U O Cheriyan
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

6.  Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens.

Authors:  L Romani; U Grohmann; F Fazioli; P Puccetti; M G Mage; M C Fioretti
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  The immunoregulatory role of bone marrow. III. Further characterization of the suppressor cell and its mode of action.

Authors:  R C McGarry; S K Singhal
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

8.  Development of Donor Recipient Chimeric Cells of bone marrow origin as a novel approach for tolerance induction in transplantation.

Authors:  Joanna Cwykiel; Maria Madajka-Niemeyer; Maria Siemionow
Journal:  Stem Cell Investig       Date:  2021-04-19

Review 9.  The Role of Trogocytosis in the Modulation of Immune Cell Functions.

Authors:  Kensuke Miyake; Hajime Karasuyama
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

10.  Antiidiotypes against anti-H-2 monoclonal antibodies. V. In vivo antiidiotype treatment induces idiotype-specific helper T cells.

Authors:  H Auchincloss; J A Bluestone; D H Sachs
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.